Azacitidine 100mg Injection

Azacitidine 100mg is an injectable hypomethylating anticancer medicine for myelodysplastic syndromes and selected related myeloid malignancies. It acts on abnormal blood-cell development in the bone marrow.
A clinical team reconstitutes the vial for the appropriate subcutaneous or intravenous regimen. Treatment is delivered in repeated cycles, often with medicine to prevent nausea. Injection sites are rotated when the subcutaneous route is used.
Azacitidine incorporates into nucleic acids and inhibits DNA methyltransferases, altering abnormal methylation and interfering with malignant-cell survival.
Low blood counts, infection, bruising, nausea, vomiting, diarrhoea, constipation and injection-site reactions can occur.
Blood counts and kidney and liver function are monitored through treatment. Fever during a low-white-cell period requires urgent assessment. Injectable and oral azacitidine are not interchangeable.
Treatment can improve blood-cell production, reduce transfusion needs and delay disease progression in responsive patients.
Several cycles may be needed before benefit becomes clear. Early blood-count changes alone do not define the final response.
No. Oral and injectable products have different exposure and treatment roles.
Abnormal marrow function and treatment-related suppression can persist before an improvement occurs.
It may indicate infection during neutropenia and needs immediate contact with the oncology team, even if other symptoms are mild.
MDS: myelodysplastic syndromes. Hypomethylating agent: medicine that reduces DNA methylation. Neutropenia: a low neutrophil count.; AR: Azacitidine 100mg حقن; FR: Azacitidine 100mg injection; PT: Azacitidine 100mg injeção; ES: Azacitidine 100mg inyección; RU: Azacitidine 100mg инъекция; ID: Azacitidine 100mg suntikan; VI: Azacitidine 100mg thuốc tiêm; MS: Azacitidine 100mg suntikan; TL: Azacitidine 100mg iniksyon; ZH-SG: Azacitidine 100mg 注射剂
International B2B Enquiry
Send a structured B2B enquiry for Azacitidine 100mg Injection under Oncology Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Azacitidine 100mg Injection